Testing effectiveness (Phase 2)Study completedNCT06017609
What this trial is testing
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
Who this might be right for
Chronic Heart Failure
Akros Pharma Inc. 314